Plasticell, Singapore Academic Institutions Collaborate
Plasticell has signed agreements with the Agency for Science, Technology and Research (A*STAR) and the Nanyang Technological University (NTU) to progress its therapeutic stem cell pipeline.
“We are delighted to have put together this collaboration which has such enormous potential for the creation of next-generation stem cell products,” commented Dr Yen Choo, founder and Executive Chairman of Plasticell.
Separate agreements with the two Singapore research centres encompass technology licensing, collaborative research and scientific exchange visits.
Plasticell will initially collaborate with the laboratories of Prof. Peter Dröge (School of Biological Sciences, NTU) and Dr. Farid Ghadessy (p53Lab, A*STAR) to apply proprietary genome editing technology to insert functional multi-transgene cassettes into specific loci of human stem cell lines. The engineered lines will be used by Plasticell in multiple projects focused on precisely directed stem cell differentiation, phenotypic screening for drug discovery and in next-generation immuno-oncology applications.
Protein Essential for Making Stem Cells IdentifiedNews
The discovery by Stanford scientists drills a peephole into the black box of cellular reprogramming and may lead to new ways to generate induced pluripotent stem cells in the laboratory.READ MORE
Chili Pepper Derived Anti-Obesity Drug Shows Promise in Animal TrialsNews
A novel drug based on capsaicin, the compound that gives chili peppers their spicy burn, caused long term weight loss and improved metabolic health in mice eating a high fat diet.READ MORE
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019